Placebo-Repaglinide [clinicaltrials_resource:b1a7bcd38b7aeb08f0470ea6f5ea9c54]
intervention [clinicaltrials_vocabulary:intervention]
Placebo-Repaglinide [clinicaltrials_resource:b1a7bcd38b7aeb08f0470ea6f5ea9c54]
Bio2RDF identifier
b1a7bcd38b7aeb08f0470ea6f5ea9c54
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b1a7bcd38b7aeb08f0470ea6f5ea9c54
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Tablet corresponding to 1 mg; two tablets three times daily.
intervention name [clinicaltrials_vocabulary:intervention-name]
Placebo-Repaglinide
identifier
clinicaltrials_resource:b1a7bcd38b7aeb08f0470ea6f5ea9c54
title
Placebo-Repaglinide
@en
type
label
Placebo-Repaglinide [clinicaltrials_resource:b1a7bcd38b7aeb08f0470ea6f5ea9c54]
@en